NAVB logo

NAVB Selling, General & Administrative Expenses

Annual SGA

$7.96 M
+$511.80 K+6.87%

December 31, 2022


Summary


Performance

NAVB SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNAVBexpensesmetrics:

Quarterly SGA

$1.30 M
-$19.70 K-1.49%

September 30, 2023


Summary


Performance

NAVB Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNAVBexpensesmetrics:

TTM SGA

-$1.55 B
-$1.39 M-0.09%

September 30, 2023


Summary


Performance

NAVB TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNAVBexpensesmetrics:

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

NAVB Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+6.9%-1.5%-10000.0%
3 y3 years+26.9%-1.5%-10000.0%
5 y5 years-28.7%-1.5%-10000.0%

NAVB Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+6.9%-64.2%+12.7%-5.6%at low
5 y5-yearat high+26.9%-64.2%+12.7%-12.6%at low
alltimeall time-48.8%+246.2%-76.3%+137.2%<-9999.0%+0.9%

Navidea Biopharmaceuticals Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2023
-
$1.30 M(-1.5%)
$5.04 M(-31.7%)
Jun 2023
-
$1.32 M(+14.4%)
$7.37 M(+0.9%)
Mar 2023
-
$1.15 M(-8.2%)
$7.31 M(-8.2%)
Dec 2022
$7.96 M(+6.9%)
$1.26 M(-65.4%)
$7.96 M(-11.7%)
Sep 2022
-
$3.64 M(+189.7%)
$9.02 M(+31.6%)
Jun 2022
-
$1.26 M(-30.6%)
$6.85 M(-2.5%)
Mar 2022
-
$1.81 M(-21.9%)
$7.03 M(-5.6%)
Dec 2021
$7.45 M(+11.3%)
$2.32 M(+57.7%)
$7.45 M(+8.3%)
Sep 2021
-
$1.47 M(+2.6%)
$6.88 M(-4.4%)
Jun 2021
-
$1.43 M(-35.8%)
$7.20 M(+1.5%)
Mar 2021
-
$2.23 M(+27.6%)
$7.10 M(+6.0%)
Dec 2020
$6.70 M(+6.7%)
$1.75 M(-2.2%)
$6.70 M(+9.5%)
Sep 2020
-
$1.79 M(+34.5%)
$6.11 M(+4.6%)
Jun 2020
-
$1.33 M(-27.3%)
$5.84 M(-8.3%)
Mar 2020
-
$1.83 M(+56.8%)
$6.37 M(+1.6%)
Dec 2019
$6.28 M(-18.5%)
$1.17 M(-23.3%)
$6.28 M(-4.2%)
Sep 2019
-
$1.52 M(-18.4%)
$6.55 M(-15.1%)
Jun 2019
-
$1.86 M(+7.7%)
$7.72 M(+0.9%)
Mar 2019
-
$1.73 M(+19.7%)
$7.65 M(-0.6%)
Dec 2018
$7.70 M(-31.1%)
$1.44 M(-46.3%)
$7.70 M(-8.5%)
Sep 2018
-
$2.69 M(+50.3%)
$8.42 M(+12.8%)
Jun 2018
-
$1.79 M(+0.7%)
$7.46 M(-24.8%)
Mar 2018
-
$1.78 M(-17.9%)
$9.92 M(-11.2%)
Dec 2017
$11.17 M(+41.0%)
$2.16 M(+24.7%)
$11.17 M(+0.7%)
Sep 2017
-
$1.73 M(-59.2%)
$11.09 M(-0.7%)
Jun 2017
-
$4.25 M(+40.6%)
$11.17 M(+34.4%)
Mar 2017
-
$3.02 M(+44.8%)
$8.31 M(+4.9%)
Dec 2016
$7.92 M(-27.3%)
$2.09 M(+15.2%)
$7.92 M(+144.8%)
Sep 2016
-
$1.81 M(+30.5%)
$3.24 M(-39.7%)
Jun 2016
-
$1.39 M(-47.3%)
$5.37 M(-33.2%)
Mar 2016
-
$2.63 M(-201.4%)
$8.03 M(-26.3%)
Dec 2015
$10.89 M(-29.9%)
-$2.60 M(-165.9%)
$10.89 M(-38.0%)
Sep 2015
-
$3.94 M(-2.6%)
$17.56 M(+8.0%)
Jun 2015
-
$4.05 M(-26.3%)
$16.27 M(-5.0%)
Mar 2015
-
$5.49 M(+34.8%)
$17.13 M(+10.2%)
Dec 2014
$15.54 M(+0.1%)
$4.08 M(+54.0%)
$15.54 M(+0.4%)
Sep 2014
-
$2.65 M(-46.1%)
$15.49 M(-7.9%)
Jun 2014
-
$4.91 M(+25.5%)
$16.81 M(+4.6%)
Mar 2014
-
$3.91 M(-2.7%)
$16.07 M(+3.5%)
Dec 2013
$15.53 M(+38.9%)
$4.02 M(+1.2%)
$15.53 M(+9.4%)
Sep 2013
-
$3.97 M(-4.8%)
$14.20 M(+7.8%)
Jun 2013
-
$4.17 M(+23.9%)
$13.17 M(+10.0%)
Mar 2013
-
$3.36 M(+25.1%)
$11.97 M(+7.1%)
Dec 2012
$11.18 M(+17.1%)
$2.69 M(-8.6%)
$11.18 M(+6.1%)
Sep 2012
-
$2.94 M(-1.0%)
$10.54 M(+0.7%)
Jun 2012
-
$2.97 M(+15.4%)
$10.46 M(+13.5%)
Mar 2012
-
$2.57 M(+25.7%)
$9.22 M(-3.4%)
Dec 2011
$9.55 M(+119.3%)
$2.05 M(-28.6%)
$9.55 M(+10.8%)
Sep 2011
-
$2.87 M(+66.2%)
$8.62 M(+22.5%)
Jun 2011
-
$1.73 M(-40.5%)
$7.04 M(+13.0%)
Mar 2011
-
$2.90 M(+159.1%)
$6.23 M(+39.8%)
Dec 2010
$4.35 M(+34.3%)
$1.12 M(-13.0%)
$4.45 M(+7.1%)
Sep 2010
-
$1.29 M(+40.2%)
$4.16 M(+13.9%)
Jun 2010
-
$918.30 K(-18.6%)
$3.65 M(+3.3%)
Mar 2010
-
$1.13 M(+37.1%)
$3.53 M(+9.0%)
Dec 2009
$3.24 M(+9.3%)
$822.70 K(+5.7%)
$3.24 M(+16.1%)
Sep 2009
-
$778.70 K(-2.9%)
$2.79 M(-1.2%)
Jun 2009
-
$801.60 K(-4.3%)
$2.83 M(-3.5%)
Mar 2009
-
$837.30 K(+124.3%)
$2.93 M(-1.3%)
Dec 2008
$2.97 M
$373.30 K(-54.1%)
$2.97 M(-10.3%)
Sep 2008
-
$812.80 K(-10.1%)
$3.31 M(+3.9%)
Jun 2008
-
$903.90 K(+3.3%)
$3.18 M(+8.7%)
DateAnnualQuarterlyTTM
Mar 2008
-
$875.40 K(+22.6%)
$2.93 M(+3.3%)
Dec 2007
$2.84 M(-7.8%)
$714.30 K(+3.5%)
$2.84 M(-3.5%)
Sep 2007
-
$690.20 K(+6.1%)
$2.94 M(+1.3%)
Jun 2007
-
$650.30 K(-16.9%)
$2.90 M(-3.4%)
Mar 2007
-
$782.60 K(-4.4%)
$3.01 M(-2.3%)
Dec 2006
$3.08 M(-2.5%)
$818.70 K(+25.7%)
$3.08 M(+0.5%)
Sep 2006
-
$651.40 K(-13.6%)
$3.06 M(-1.2%)
Jun 2006
-
$753.80 K(-11.6%)
$3.10 M(-2.3%)
Mar 2006
-
$852.50 K(+6.2%)
$3.17 M(+0.5%)
Dec 2005
$3.16 M(+0.1%)
$802.70 K(+16.5%)
$3.16 M(+0.4%)
Sep 2005
-
$689.00 K(-16.8%)
$3.14 M(-0.2%)
Jun 2005
-
$827.80 K(-1.0%)
$3.15 M(-0.8%)
Mar 2005
-
$836.10 K(+5.7%)
$3.18 M(+0.7%)
Dec 2004
$3.15 M(+1.6%)
$791.10 K(+13.8%)
$3.15 M(-2.5%)
Sep 2004
-
$695.40 K(-18.5%)
$3.23 M(-1.8%)
Jun 2004
-
$853.10 K(+4.9%)
$3.29 M(+4.2%)
Mar 2004
-
$813.40 K(-6.7%)
$3.16 M(+1.9%)
Dec 2003
$3.10 M(-5.0%)
$871.80 K(+15.5%)
$3.10 M(+1.6%)
Sep 2003
-
$755.10 K(+4.7%)
$3.05 M(-2.2%)
Jun 2003
-
$721.50 K(-4.3%)
$3.12 M(-0.8%)
Mar 2003
-
$754.10 K(-8.4%)
$3.15 M(-3.0%)
Dec 2002
$3.27 M(+40.8%)
$823.40 K(-0.0%)
$3.24 M(+6.7%)
Sep 2002
-
$823.60 K(+10.5%)
$3.04 M(+10.3%)
Jun 2002
-
$745.60 K(-12.3%)
$2.75 M(+5.9%)
Mar 2002
-
$850.60 K(+37.5%)
$2.60 M(+12.1%)
Dec 2001
$2.32 M(-21.6%)
$618.70 K(+14.8%)
$2.32 M(-12.9%)
Sep 2001
-
$538.90 K(-9.0%)
$2.66 M(-2.2%)
Jun 2001
-
$592.50 K(+3.9%)
$2.72 M(-1.0%)
Mar 2001
-
$570.30 K(-40.6%)
$2.75 M(-7.1%)
Dec 2000
$2.96 M(-63.9%)
$960.90 K(+60.2%)
$2.96 M(+48.1%)
Sep 2000
-
$599.70 K(-3.4%)
$2.00 M(+42.8%)
Jun 2000
-
$620.60 K(-20.4%)
$1.40 M(-47.8%)
Mar 2000
-
$779.20 K(-59.0%)
$2.68 M(-73.4%)
Dec 1999
$8.21 M(-27.7%)
-
-
Jun 1999
-
$1.90 M(-13.6%)
$10.06 M(-4.7%)
Mar 1999
-
$2.20 M(-30.3%)
$10.56 M(-8.7%)
Dec 1998
$11.36 M(+1.8%)
$3.16 M(+12.7%)
$11.56 M(-0.0%)
Sep 1998
-
$2.80 M(+16.7%)
$11.56 M(+2.7%)
Jun 1998
-
$2.40 M(-25.0%)
$11.26 M(-4.3%)
Mar 1998
-
$3.20 M(+1.3%)
$11.76 M(+6.3%)
Dec 1997
$11.16 M(+43.1%)
$3.16 M(+26.4%)
$11.06 M(-0.4%)
Sep 1997
-
$2.50 M(-13.8%)
$11.10 M(+2.8%)
Jun 1997
-
$2.90 M(+16.0%)
$10.80 M(+14.9%)
Mar 1997
-
$2.50 M(-21.9%)
$9.40 M(+14.6%)
Dec 1996
$7.80 M(+116.7%)
$3.20 M(+45.5%)
$8.20 M(+34.4%)
Sep 1996
-
$2.20 M(+46.7%)
$6.10 M(+24.5%)
Jun 1996
-
$1.50 M(+15.4%)
$4.90 M(+11.4%)
Mar 1996
-
$1.30 M(+18.2%)
$4.40 M(+10.0%)
Dec 1995
$3.60 M(-70.0%)
$1.10 M(+10.0%)
$4.00 M(-45.2%)
Sep 1995
-
$1.00 M(0.0%)
$7.30 M(-20.7%)
Jun 1995
-
$1.00 M(+11.1%)
$9.20 M(+3.4%)
Mar 1995
-
$900.00 K(-79.5%)
$8.90 M(0.0%)
Dec 1994
$12.00 M(+421.7%)
$4.40 M(+51.7%)
$8.90 M(+790.0%)
Sep 1994
-
$2.90 M(+314.3%)
$1.00 M(+150.0%)
Jun 1994
-
$700.00 K(-22.2%)
$400.00 K(-77.8%)
Mar 1994
-
$900.00 K(-125.7%)
$1.80 M(-21.7%)
Dec 1993
$2.30 M(-20.7%)
-$3.50 M(-252.2%)
$2.30 M(-66.2%)
Sep 1993
-
$2.30 M(+9.5%)
$6.80 M(+25.9%)
Jun 1993
-
$2.10 M(+50.0%)
$5.40 M(+63.6%)
Mar 1993
-
$1.40 M(+40.0%)
$3.30 M(+73.7%)
Dec 1992
$2.90 M
$1.00 M(+11.1%)
$1.90 M(+111.1%)
Sep 1992
-
$900.00 K
$900.00 K

FAQ

  • What is Navidea Biopharmaceuticals annual SGA?
  • What is the all time high annual SGA for Navidea Biopharmaceuticals?
  • What is Navidea Biopharmaceuticals annual SGA year-on-year change?
  • What is Navidea Biopharmaceuticals quarterly SGA?
  • What is the all time high quarterly SGA for Navidea Biopharmaceuticals?
  • What is Navidea Biopharmaceuticals quarterly SGA year-on-year change?
  • What is Navidea Biopharmaceuticals TTM SGA?
  • What is the all time high TTM SGA for Navidea Biopharmaceuticals?
  • What is Navidea Biopharmaceuticals TTM SGA year-on-year change?

What is Navidea Biopharmaceuticals annual SGA?

The current annual SGA of NAVB is $7.96 M

What is the all time high annual SGA for Navidea Biopharmaceuticals?

Navidea Biopharmaceuticals all-time high annual SGA is $15.54 M

What is Navidea Biopharmaceuticals annual SGA year-on-year change?

Over the past year, NAVB annual SGA has changed by +$511.80 K (+6.87%)

What is Navidea Biopharmaceuticals quarterly SGA?

The current quarterly SGA of NAVB is $1.30 M

What is the all time high quarterly SGA for Navidea Biopharmaceuticals?

Navidea Biopharmaceuticals all-time high quarterly SGA is $5.49 M

What is Navidea Biopharmaceuticals quarterly SGA year-on-year change?

Over the past year, NAVB quarterly SGA has changed by -$19.70 K (-1.49%)

What is Navidea Biopharmaceuticals TTM SGA?

The current TTM SGA of NAVB is -$1.55 B

What is the all time high TTM SGA for Navidea Biopharmaceuticals?

Navidea Biopharmaceuticals all-time high TTM SGA is -$13.00 M

What is Navidea Biopharmaceuticals TTM SGA year-on-year change?

Over the past year, NAVB TTM SGA has changed by -$1.55 B (-21084.28%)